FIELD: medicine.
SUBSTANCE: blood is drawn off, stabilised to recover thrombocyte-enriched plasma (TEP) and applied on a slide where thrombocyte aggregation test with a number of inducers is performed. In this environment, the visual evaluation of thrombocyte aggregation allows creating a real model of blood flow with small volume (0.02 ml.) of plasma and small volume of inducers with using minimum mutually potentiating concentrations of inducers, with necessary application of collagen in the combinations and calculation of "СЗИАК" the value of which is used to observe fine disorders of thrombocyte aggregation.
EFFECT: improved clinical effectiveness.
4 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATION OF THROMBOCYTE AGGREGATION | 2009 |
|
RU2390027C1 |
| METHOD FOR PREDICTING INITIAL SIGNS OF HUMAN AND ANIMAL AFFECTED THROMBOCYTIC AGGREGATION | 2004 |
|
RU2279682C1 |
| METHOD FOR OPTIMISATION OF THROMBOCYTE RECEPTIVITY TO AGGREGATION INDUCERS IN METABOLIC SYNDROME | 2007 |
|
RU2339379C1 |
| METHOD FOR NORMALISATION OF PLATELET SENSITIVITY TO AGGREGATION INDUCERS IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROME | 2007 |
|
RU2342141C1 |
| METHOD OF BLOOD PLATELET NORMALISATION UNDER METABOLIC SYNDROME | 2007 |
|
RU2344814C1 |
| METHOD OF NEWBORN CALVES' DYSPEPSIA TREATMENT | 2006 |
|
RU2327467C1 |
| METHOD OF DISPERSION TREATMENT IN NEWBORN CALVES AND PIGLETS | 2007 |
|
RU2356542C1 |
| METHOD FOR STUDYING THROMBOCYTIC AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AT METABOLIC SYNDROME | 2003 |
|
RU2250461C2 |
| METHOD OF NORMALISATION OF THROMBOCYTE SUSCEPTIBILITY TO AGGREGATION STIMULATION AGENTS FOR ARTERIAL HYPERTENSION PATIENTS UNDER METABOLIC SYNDROME | 2007 |
|
RU2344815C1 |
| EARLY STAGE DIAGNOSIS METHOD FOR DETECTING THROMBOPHILIC THROMBOCYTOPATHY IN METABOLIC SYNDROME CASES | 2004 |
|
RU2275641C1 |
